Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Plos One
|
March 10, 2012
A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden
Lasse Kjær, Maj Westman, Caroline Hasselbalch Riley, et al.
Current Drug Targets
|
December 15, 2010
Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives
Hans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, et al.
Oncoimmunology
|
September 20, 2018
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation
Mia Aaboe Jørgensen, Morten Orebo Holmström, Evelina Martinenaite, et al.
Oncoimmunology
|
June 7, 2018
Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response
Morten Orebo Holmström, Caroline Hasselbalch Riley, Vibe Skov, et al.
Ugeskrift for Laeger
|
March 6, 2024
Bue Ross Agner, Caroline Hasselbalch Riley, Søren Lykke Petersen, et al.
Diagnostic Microbiology and Infectious Disease
|
July 12, 2025
Borrelia afzelii-associated seronegative Lyme neuroborreliosis in an immunocompromised patient
Freja Gustafsson, Ann-Brit Eg Hansen, Kurt Fuursted, et al.
Leukemia & Lymphoma
|
May 10, 2015
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
Cecilie Utke Rank, Ole Weis Bjerrum, Thomas Stauffer Larsen, et al.
Blood
|
June 29, 2011
Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α
Caroline Hasselbalch Riley, Morten Krogh Jensen, Marie Klinge Brimnes, et al.
Leukemia & Lymphoma
|
December 3, 2016
The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms
Vibe Skov, Caroline Hasselbalch Riley, Mads Thomassen, et al.
European Journal of Haematology
|
March 31, 2011
Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Plos One
|
March 10, 2012
A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden
Lasse Kjær, Maj Westman, Caroline Hasselbalch Riley, et al.
Current Drug Targets
|
December 15, 2010
Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives
Hans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, et al.
Oncoimmunology
|
September 20, 2018
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation
Mia Aaboe Jørgensen, Morten Orebo Holmström, Evelina Martinenaite, et al.
Oncoimmunology
|
June 7, 2018
Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response
Morten Orebo Holmström, Caroline Hasselbalch Riley, Vibe Skov, et al.
Ugeskrift for Laeger
|
March 6, 2024
Bue Ross Agner, Caroline Hasselbalch Riley, Søren Lykke Petersen, et al.
Diagnostic Microbiology and Infectious Disease
|
July 12, 2025
Borrelia afzelii-associated seronegative Lyme neuroborreliosis in an immunocompromised patient
Freja Gustafsson, Ann-Brit Eg Hansen, Kurt Fuursted, et al.
Leukemia & Lymphoma
|
May 10, 2015
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
Cecilie Utke Rank, Ole Weis Bjerrum, Thomas Stauffer Larsen, et al.
Blood
|
June 29, 2011
Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α
Caroline Hasselbalch Riley, Morten Krogh Jensen, Marie Klinge Brimnes, et al.
Leukemia & Lymphoma
|
December 3, 2016
The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms
Vibe Skov, Caroline Hasselbalch Riley, Mads Thomassen, et al.
European Journal of Haematology
|
March 31, 2011
Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, et al.
Page
of 3